Breast DWI Analyzed Before and After Gadolinium Contrast Administration—An Intrapatient Analysis on 1.5 T and 3.0 T

From the Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands (K.J.J.H., R.-J.S., R.W., R.G.H.B., R.M.M.); GROW School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands (K.J.J.H., R.G.H.B.); Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, the Netherlands (R.-J.S.); Department of Medical Physics, the Netherlands Cancer Institute, Amsterdam, the Netherlands (L.C.B.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (R.M.M.); and Danish Colorectal Cancer Unit South, Vejle University Hospital, Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark (R.G.H.B.).

Received for publication March 6, 2023; and accepted for publication, after revision, May 4, 2023.

Conflicts of interest and sources of funding: R.M.M. (research agreements: Siemens Healthineers, Bayer Healthcare, ScreenPoint Medical, Seno Medical, Koning, Medtronic, BD/Bard). The authors state that this work has not received any funding.

Correspondence to: Kay J.J. van der Hoogt, MSc, Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. E-mail: [email protected].

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com).

Comments (0)

No login
gif